UBS Group
CC icon

UBS Group’s Chemours CC Stock Holding History

UBS Group’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,100
Closed -$1.7M – 9502
2023
Q2 		$1.7M Hold
46,100
– – ﹤0.01% 3692
2023
Q1 		$1.38M Buy
+46,100
New +$1.52M ﹤0.01% 3813
2017
Q2 		– Sell
-128,200
Closed -$4.94M – 7691
2017
Q1 		$4.94M Buy
+128,200
New +$3.86M ﹤0.01% 2094

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

UBS Group's CC Position: Q2 2026 in Review

UBS Group reduced its Chemours (CC) stake by 6.3% in Q2 2026, selling an estimated $3.98M and leaving 2,593,745 shares worth $53.2M. The position accounts for 0.01% of the portfolio, ranked #1686.

UBS Group first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $75.3M in Q3 2025. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • UBS Group held 2,593,745 shares of Chemours worth $53.2M as of Q2 2026.
  • UBS Group sold 174,061 Chemours shares in Q2 2026, an estimated $3.98M.
  • Chemours made up 0.01% of UBS Group's portfolio in Q2 2026, its #1686 holding.
  • UBS Group first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
  • UBS Group's Chemours position peaked at $75.3M in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.